BlackRock’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $94.1M | Sell |
10,027,175
-529,015
| -5% | -$4.96M | ﹤0.01% | 2065 |
|
|
2025
Q1 | $75.1M | Sell |
10,556,190
-301,503
| -3% | -$2.14M | ﹤0.01% | 2149 |
|
|
2024
Q4 | $127M | Buy |
10,857,693
+1,084,951
| +11% | +$12.7M | ﹤0.01% | 1928 |
|
|
2024
Q3 | $201M | Buy |
9,772,742
+175,135
| +2% | +$3.6M | ﹤0.01% | 1647 |
|
|
2024
Q2 | $215M | Buy |
9,597,607
+488,339
| +5% | +$10.9M | ﹤0.01% | 1558 |
|
|
2024
Q1 | $251M | Buy |
9,109,268
+98,573
| +1% | +$2.71M | 0.01% | 1485 |
|
|
2023
Q4 | $275M | Buy |
9,010,695
+877,905
| +11% | +$26.8M | 0.01% | 1414 |
|
|
2023
Q3 | $257M | Buy |
8,132,790
+77,827
| +1% | +$2.46M | 0.01% | 1369 |
|
|
2023
Q2 | $328M | Buy |
8,054,963
+706,344
| +10% | +$28.8M | 0.01% | 1218 |
|
|
2023
Q1 | $274M | Buy |
7,348,619
+93,373
| +1% | +$3.48M | 0.01% | 1316 |
|
|
2022
Q4 | $253M | Buy |
7,255,246
+1,127,106
| +18% | +$39.3M | 0.01% | 1356 |
|
|
2022
Q3 | $343M | Buy |
6,128,140
+240,741
| +4% | +$13.5M | 0.01% | 1070 |
|
|
2022
Q2 | $305M | Buy |
5,887,399
+285,660
| +5% | +$14.8M | 0.01% | 1210 |
|
|
2022
Q1 | $407M | Sell |
5,601,739
-18,637
| -0.3% | -$1.35M | 0.01% | 1124 |
|
|
2021
Q4 | $665M | Buy |
5,620,376
+89,381
| +2% | +$10.6M | 0.02% | 817 |
|
|
2021
Q3 | $742M | Buy |
5,530,995
+565,430
| +11% | +$75.9M | 0.02% | 710 |
|
|
2021
Q2 | $804M | Sell |
4,965,565
-306,061
| -6% | -$49.6M | 0.02% | 699 |
|
|
2021
Q1 | $423M | Buy |
5,271,626
+218,781
| +4% | +$17.6M | 0.01% | 1151 |
|
|
2020
Q4 | $275M | Sell |
5,052,845
-592,164
| -10% | -$32.2M | 0.01% | 1364 |
|
|
2020
Q3 | $112M | Buy |
5,645,009
+594,183
| +12% | +$11.8M | ﹤0.01% | 1792 |
|
|
2020
Q2 | $106M | Buy |
5,050,826
+1,258,528
| +33% | +$26.5M | ﹤0.01% | 1796 |
|
|
2020
Q1 | $46.4M | Buy |
3,792,298
+147,068
| +4% | +$1.8M | ﹤0.01% | 2074 |
|
|
2019
Q4 | $53.5M | Buy |
3,645,230
+64,632
| +2% | +$948K | ﹤0.01% | 2299 |
|
|
2019
Q3 | $47.8M | Buy |
3,580,598
+190,331
| +6% | +$2.54M | ﹤0.01% | 2297 |
|
|
2019
Q2 | $55.5M | Buy |
3,390,267
+208,548
| +7% | +$3.41M | ﹤0.01% | 2250 |
|
|
2019
Q1 | $54.3M | Buy |
3,181,719
+312,981
| +11% | +$5.35M | ﹤0.01% | 2213 |
|
|
2018
Q4 | $39.2M | Buy |
2,868,738
+124,341
| +5% | +$1.7M | ﹤0.01% | 2369 |
|
|
2018
Q3 | $78.5M | Buy |
2,744,397
+188,098
| +7% | +$5.38M | ﹤0.01% | 2113 |
|
|
2018
Q2 | $69.9M | Buy |
2,556,299
+833,337
| +48% | +$22.8M | ﹤0.01% | 2153 |
|
|
2018
Q1 | $36.3M | Buy |
1,722,962
+12,015
| +0.7% | +$253K | ﹤0.01% | 2440 |
|
|
2017
Q4 | $32.9M | Buy |
1,710,947
+31,662
| +2% | +$609K | ﹤0.01% | 2496 |
|
|
2017
Q3 | $41.7M | Buy |
1,679,285
+3,949
| +0.2% | +$98.1K | ﹤0.01% | 2372 |
|
|
2017
Q2 | $26.8M | Buy |
1,675,336
+731,992
| +78% | +$11.7M | ﹤0.01% | 2606 |
|
|
2017
Q1 | $13.3M | Buy |
943,344
+942,943
| +235,148% | +$13.3M | ﹤0.01% | 2959 |
|
|
2016
Q4 | $5K | Hold |
401
| – | – | ﹤0.01% | 3464 |
|
|
2016
Q3 | $7K | Sell |
401
-2,063
| -84% | -$36K | ﹤0.01% | 3395 |
|
|
2016
Q2 | $53K | Buy |
+2,464
| New | +$53K | ﹤0.01% | 2867 |
|